The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
22 February 2023
1) CTF
Meeting with DG Grow
GML is working on sending the letter to DG GROW. It will go out as soon as he has approval from the other 4 organisations.
CTF chairs
Rahul and Ian stepped down. WG1 and the Steering Group were informed.
2) Policy updates
WHO Europe | Novel Medicines Platform – Consultation with non-State actors
@ PH – could you please report back from the meeting on 8 February?
PRAC | Request for information on prescription/dispensing software in hospitals
DKP would like to discuss a request received from Roberto Frontini. More information HERE.
EPSA Annual Reception
LB will attend.
EPF | dates for virtual meeting with EPF president
@ AS – when in April would you have availability for a virtual meeting with EPF’s president?
EAHP Investigation
@ DKP – would you be willing to meet with the winner of the “drink with a Board member” during the Get Together Reception? (meeting point 19.00 EAHP Booth)
Open items
Please respond to the following overdue emails:
AS/DKP – EHMA speaker
DKP – FIP award
DKP – MD questions DP
3) Consultations – state of play
Due date | Type of consultation | Action |
26/02/2023 | EMA – ICH M11 guideline on Clinical Electronic Structured Harmonised Protocol and template | Submitted. |
03/03/2023 | EMA – ACT EU multi-stakeholder platform | Submitted. |
14/03/2023 | COM – Urban wastewater treatment update & Surface and groundwater pollutants | Feedback in preparation. |
15/03/2023 | COM – Revision of rules on packaging and packaging waste | Interesting but we don’t have the capacity to engage. |
15/03/2023 | COM – Revision of EU legislation on hazard classification, labelling and packaging of chemicals | Interesting but we don’t have the capacity to engage. |
31/03/2023 | EDQM – Pead Forum: draft monograph on a Chloral Hydrate Oral Solution | Awaiting final confirmation from PH & AL. |
31/05/2023 | EMA – Reflection paper on criteria to be considered for the evaluation of new active substance (NAS) status of biological substances | Shared with EMA & ATMP Board leads. Awaiting feedback. |
Next policy call? 6 March 2 PM | 9 March 2 PM | week of 13 March